Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2009 by Yale University.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Novartis
Genentech, Inc.
Information provided by:
Yale University
ClinicalTrials.gov Identifier:
NCT00461773
First received: April 16, 2007
Last updated: June 5, 2009
Last verified: June 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2010
  Estimated Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)